Cargando…

Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1

Breast cancer is a heterogeneous disease that includes different molecular subtypes. The basal-like subtype has a poor prognosis and a high recurrence rate, whereas the luminal-like subtype confers a more favorable patient prognosis partially due to anti-hormone therapy responsiveness. Here, we demo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Minmin, Chen, Jingwei, Gao, Jian, Xue, Wenwen, Wang, Yixuan, Li, Wuhao, Zhou, Lin, Li, Xin, Jiang, Chengfei, Sun, Yang, Wu, Xuefeng, Wu, Xudong, Ge, Huiming, Shen, Yan, Xu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429843/ https://www.ncbi.nlm.nih.gov/pubmed/32801338 http://dx.doi.org/10.1038/s41419-020-02878-z

Ejemplares similares

Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells
por: Gao, Jian, et al.
Publicado: (2017)

Diptoindonesin G, a new Hsp90 drug
por: Wickramaratne, Anushka, et al.
Publicado: (2022)

Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment
por: Donahue, Kristine, et al.
Publicado: (2022)

Symmetry-based approach to oligostilbenoids: Rapid entry to viniferifuran, shoreaphenol, malibatol A, and diptoindonesin G
por: Jung, Youngeun, et al.
Publicado: (2016)

A new crystal form of GABARAPL2
por: Scicluna, Kristen, et al.
Publicado: (2021)

Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer
por: Fan, Minmin, et al.
Publicado: (2022)

Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation
por: Sha, Zhe, et al.
Publicado: (2018)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Specific Distribution of the Autophagic Protein GABARAPL1/GEC1 in the Developing and Adult Mouse Brain and Identification of Neuronal Populations Expressing GABARAPL1/GEC1
por: Le Grand, Jaclyn Nicole, et al.
Publicado: (2013)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer
por: Xue, Wenwen, et al.
Publicado: (2022)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models
por: Hervouet, Eric, et al.
Publicado: (2015)

The NMD Pathway Regulates GABARAPL1 mRNA during the EMT
por: Baudu, Timothée, et al.
Publicado: (2021)

Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
por: Jia, Rong, et al.
Publicado: (2020)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback
por: Jacquet, Marine, et al.
Publicado: (2021)

Insulin Inhibits Autophagy by Inhibiting the Binding of FoXO1 to the Promoter Region of GABARAPL1
por: Hong, Tao, et al.
Publicado: (2023)

Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes
por: Feng, Chao, et al.
Publicado: (2021)

GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer
por: Su, Wei, et al.
Publicado: (2016)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
por: Ravanini, Juliana Naves, et al.
Publicado: (2021)

Correction: Insulin Inhibits Autophagy by Inhibiting the Binding of FoXO1 to the Promoter Region of GABARAPL1
por: Hong, Tao, et al.
Publicado: (2023)

Autophagic Network Analysis of the Dual Effect of Sevoflurane on Neurons Associated with GABARAPL1 and 2
por: Lu, Guolin, et al.
Publicado: (2020)

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications
por: Barth, Isabella, et al.
Publicado: (2018)

Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma
por: Du, Xiaojing, et al.
Publicado: (2022)

FKBP4 is a malignant indicator in luminal A subtype of breast cancer
por: Xiong, Hanchu, et al.
Publicado: (2020)

GABARAPL1 acts as a potential marker and promotes tumor proliferation and metastasis in triple negative breast cancer
por: Ran, Li, et al.
Publicado: (2017)

Inference of tissue relative proportions of the breast epithelial cell types luminal progenitor, basal, and luminal mature
por: Bartlett, Thomas E., et al.
Publicado: (2021)

Coding strategy for surface luminance switches in the primary visual cortex of the awake monkey
por: Yang, Yi, et al.
Publicado: (2022)

The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype
por: Need, Eleanor F., et al.
Publicado: (2015)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

The Immune System GTPase GIMAP6 Interacts with the Atg8 Homologue GABARAPL2 and Is Recruited to Autophagosomes
por: Pascall, John C., et al.
Publicado: (2013)

Secretion of pro‐angiogenic extracellular vesicles during hypoxia is dependent on the autophagy‐related protein GABARAPL1
por: Keulers, Tom G., et al.
Publicado: (2021)

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
por: Reis, Leonardo Oliveira
Publicado: (2016)

Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
por: Dhawan, Deepika, et al.
Publicado: (2018)

Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A–Type Breast Cancer
por: Klebe, Max, et al.
Publicado: (2020)

High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer
por: Berthier, A, et al.
Publicado: (2010)

MicroRNA-195 regulates proliferation, migration, angiogenesis and autophagy of endothelial progenitor cells by targeting GABARAPL1
por: Mo, Jianwen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_176i1u1pfom39s5t1eie7kflcu